25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

0QF (Moderna Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Moderna Inc together

I guess you are interested in Moderna Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Moderna Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Moderna Inc’s Price Targets

I'm going to help you getting a better view of Moderna Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Moderna Inc

I send you an email if I find something interesting about Moderna Inc.

1. Quick Overview

1.1. Quick analysis of Moderna Inc (30 sec.)










1.2. What can you expect buying and holding a share of Moderna Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€22.30
Expected worth in 1 year
€16.20
How sure are you?
56.5%

+ What do you gain per year?

Total Gains per Share
€-6.09
Return On Investment
-21.1%

For what price can you sell your share?

Current Price per Share
€28.95
Expected price per share
€24.91 - €34.90
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Moderna Inc (5 min.)




Live pricePrice per Share (EOD)
€28.95
Intrinsic Value Per Share
€-421.89 - €-506.03
Total Value Per Share
€-399.59 - €-483.74

2.2. Growth of Moderna Inc (5 min.)




Is Moderna Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$10b$14.2b-$3.1b-28.0%

How much money is Moderna Inc making?

Current yearPrevious yearGrowGrow %
Making money-$839.2m-$1.4b$652.7m77.8%
Net Profit Margin-400.7%-323.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Moderna Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#13 / 872

Most Revenue
#20 / 872

Most Profit
#870 / 872

Most Efficient
#633 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Moderna Inc?

Welcome investor! Moderna Inc's management wants to use your money to grow the business. In return you get a share of Moderna Inc.

First you should know what it really means to hold a share of Moderna Inc. And how you can make/lose money.

Speculation

The Price per Share of Moderna Inc is €28.95. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Moderna Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Moderna Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €22.30. Based on the TTM, the Book Value Change Per Share is €-1.52 per quarter. Based on the YOY, the Book Value Change Per Share is €-3.35 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Moderna Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps-2.51-8.7%-2.17-7.5%-3.86-13.3%-1.30-4.5%1.113.8%0.923.2%
Usd Book Value Change Per Share-2.16-7.5%-1.78-6.1%-3.91-13.5%-1.39-4.8%1.093.8%1.133.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-2.16-7.5%-1.78-6.1%-3.91-13.5%-1.39-4.8%1.093.8%1.133.9%
Usd Price Per Share30.97-68.88-116.17-117.15-142.33-126.74-
Price to Earnings Ratio-3.08-125.61-6.20-45.77-23.18-17.83-
Price-to-Total Gains Ratio-14.34-12.22-4.76-14.91-1.35--1.85-
Price to Book Ratio1.19-2.33-3.17-3.00-6.35-6.36-
Price-to-Total Gains Ratio-14.34-12.22-4.76-14.91-1.35--1.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share33.790393
Number of shares29
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.781.09
Usd Total Gains Per Share-1.781.09
Gains per Quarter (29 shares)-51.5731.59
Gains per Year (29 shares)-206.28126.35
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-206-2160126116
20-413-4220253242
30-619-6280379368
40-825-8340505494
50-1031-10400632620
60-1238-12460758746
70-1444-14520884872
80-1650-165801011998
90-1857-1864011371124
100-2063-2070012641250

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%5.07.00.041.7%10.010.00.050.0%10.013.00.043.5%10.013.00.043.5%
Book Value Change Per Share1.03.00.025.0%5.07.00.041.7%11.09.00.055.0%13.010.00.056.5%13.010.00.056.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.023.00.0%0.00.023.00.0%
Total Gains per Share1.03.00.025.0%5.07.00.041.7%11.09.00.055.0%13.010.00.056.5%13.010.00.056.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Moderna Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.849-1.523-18%-3.348+81%-1.189-36%0.933-298%0.969-291%
Book Value Per Share--22.29524.700-10%31.604-29%32.373-31%25.843-14%22.864-2%
Current Ratio--4.2184.092+3%3.329+27%3.331+27%3.432+23%4.053+4%
Debt To Asset Ratio--0.2080.234-11%0.254-18%0.254-18%0.343-40%0.328-37%
Debt To Equity Ratio--0.2620.306-14%0.343-24%0.344-24%0.650-60%0.604-57%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--8000554884.48019878515066.480-60%34328156767.200-77%34499793643.413-77%43041780838.293-81%38369025787.168-79%
Eps---2.151-1.859-14%-3.305+54%-1.113-48%0.952-326%0.792-371%
Ev To Sales Ratio--21.82220.248+8%25.634-15%16.791+30%18.989+15%41.368-47%
Free Cash Flow Per Share---2.578-2.234-13%-2.033-21%-1.310-49%1.136-327%1.070-341%
Free Cash Flow To Equity Per Share---2.569-2.208-14%-2.488-3%-2.091-19%0.665-487%0.682-477%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---506.033----------
Intrinsic Value_10Y_min---421.885----------
Intrinsic Value_1Y_max---11.838----------
Intrinsic Value_1Y_min---11.605----------
Intrinsic Value_3Y_max---65.192----------
Intrinsic Value_3Y_min---61.639----------
Intrinsic Value_5Y_max---154.260----------
Intrinsic Value_5Y_min---140.631----------
Market Cap11194247653.120+8%10260265684.48022817295516.480-55%38485664867.200-73%38872451110.080-74%48122428384.223-79%42830941296.611-76%
Net Profit Margin---9.075-4.007-56%-3.238-64%-2.320-74%-1.417-84%-2.571-72%
Operating Margin----0%-1.6320%-0.4430%-0.2690%-1.4700%
Operating Ratio--11.6545.933+96%5.590+108%4.211+177%2.977+291%4.131+182%
Pb Ratio1.298+8%1.1902.333-49%3.166-62%2.995-60%6.353-81%6.361-81%
Pe Ratio-3.365-9%-3.084125.609-102%6.203-150%45.774-107%23.185-113%17.835-117%
Price Per Share28.945+8%26.53058.999-55%99.513-73%100.349-74%121.924-78%108.569-76%
Price To Free Cash Flow Ratio-2.807-9%-2.573-0.215-92%-0.413-84%13.100-120%3.031-185%1.457-277%
Price To Total Gains Ratio-15.651-9%-14.34512.219-217%4.764-401%14.912-196%1.351-1161%-1.847-87%
Quick Ratio--2.7622.733+1%2.052+35%2.099+32%1.855+49%2.420+14%
Return On Assets---0.076-0.059-23%-0.077+1%-0.030-61%0.014-653%0.003-2966%
Return On Equity---0.096-0.077-20%-0.107+11%-0.039-59%0.046-311%0.028-448%
Total Gains Per Share---1.849-1.523-18%-3.348+81%-1.189-36%0.933-298%0.969-291%
Usd Book Value--10065948059.44011151442458.260-10%14268676373.250-29%14636924473.080-31%11789842064.101-15%10428883099.729-3%
Usd Book Value Change Per Share---2.159-1.778-18%-3.908+81%-1.388-36%1.089-298%1.132-291%
Usd Book Value Per Share--26.02828.834-10%36.895-29%37.792-31%30.170-14%26.692-2%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--9339847772.14223206178488.609-60%40074690210.029-77%40275059099.321-77%50246974950.623-81%44792000703.940-79%
Usd Eps---2.511-2.170-14%-3.858+54%-1.299-48%1.112-326%0.925-371%
Usd Free Cash Flow---1163993993.760-1008494796.140-13%-917995263.120-21%-591163616.247-49%547244026.206-313%470976830.617-347%
Usd Free Cash Flow Per Share---3.010-2.608-13%-2.374-21%-1.529-49%1.326-327%1.249-341%
Usd Free Cash Flow To Equity Per Share---2.999-2.578-14%-2.904-3%-2.441-19%0.776-487%0.796-477%
Usd Market Cap13068164710.252+8%11977834160.06226636910785.939-55%44928165165.969-73%45379699425.907-74%56178122895.742-79%50000840869.664-76%
Usd Price Per Share33.790+8%30.97168.875-55%116.171-73%117.147-74%142.334-78%126.743-76%
Usd Profit---970994989.640-839245669.470-14%-1491992301.280+54%-378414714.037-61%534755540.647-282%448894466.301-316%
Usd Revenue--106999447.880784745950.690-86%1288743350.050-92%1918823432.153-94%2417887823.634-96%2104228098.649-95%
Usd Total Gains Per Share---2.159-1.778-18%-3.908+81%-1.388-36%1.089-298%1.132-291%
 EOD+5 -3MRQTTM+9 -26YOY+17 -183Y+9 -265Y+9 -2610Y+8 -27

3.3 Fundamental Score

Let's check the fundamental score of Moderna Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.365
Price to Book Ratio (EOD)Between0-11.298
Net Profit Margin (MRQ)Greater than0-9.075
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.762
Current Ratio (MRQ)Greater than14.218
Debt to Asset Ratio (MRQ)Less than10.208
Debt to Equity Ratio (MRQ)Less than10.262
Return on Equity (MRQ)Greater than0.15-0.096
Return on Assets (MRQ)Greater than0.05-0.076
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Moderna Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.326
Ma 20Greater thanMa 5024.516
Ma 50Greater thanMa 10023.753
Ma 100Greater thanMa 20025.806
OpenGreater thanClose29.320
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Moderna Inc

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Fundamental data was last updated by Penke on 2025-06-25 21:08:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Moderna Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Moderna Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -907.5%Β means thatΒ €-9.07 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Moderna Inc:

  • The MRQ is -907.5%. The company is making a huge loss. -2
  • The TTM is -400.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-907.5%TTM-400.7%-506.8%
TTM-400.7%YOY-323.8%-76.8%
TTM-400.7%5Y-141.7%-259.0%
5Y-141.7%10Y-257.1%+115.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-907.5%-91.7%-815.8%
TTM-400.7%-140.3%-260.4%
YOY-323.8%-196.4%-127.4%
3Y-232.0%-247.9%+15.9%
5Y-141.7%-343.3%+201.6%
10Y-257.1%-488.1%+231.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Moderna Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Moderna Inc to theΒ Biotechnology industry mean.
  • -7.6% Return on Assets means thatΒ Moderna Inc generatedΒ €-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Moderna Inc:

  • The MRQ is -7.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.6%TTM-5.9%-1.7%
TTM-5.9%YOY-7.7%+1.8%
TTM-5.9%5Y1.4%-7.3%
5Y1.4%10Y0.3%+1.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.6%-11.5%+3.9%
TTM-5.9%-11.5%+5.6%
YOY-7.7%-11.4%+3.7%
3Y-3.0%-11.7%+8.7%
5Y1.4%-11.9%+13.3%
10Y0.3%-13.7%+14.0%
4.3.1.3. Return on Equity

Shows how efficient Moderna Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Moderna Inc to theΒ Biotechnology industry mean.
  • -9.6% Return on Equity means Moderna Inc generated €-0.10Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Moderna Inc:

  • The MRQ is -9.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.6%TTM-7.7%-2.0%
TTM-7.7%YOY-10.7%+3.0%
TTM-7.7%5Y4.6%-12.3%
5Y4.6%10Y2.8%+1.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.6%-13.6%+4.0%
TTM-7.7%-14.8%+7.1%
YOY-10.7%-14.4%+3.7%
3Y-3.9%-16.8%+12.9%
5Y4.6%-17.5%+22.1%
10Y2.8%-19.5%+22.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Moderna Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Moderna Inc is operatingΒ .

  • Measures how much profit Moderna Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Moderna Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated €0.00 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Moderna Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-163.2%+163.2%
TTM-5Y-26.9%+26.9%
5Y-26.9%10Y-147.0%+120.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--221.8%+221.8%
TTM--250.7%+250.7%
YOY-163.2%-208.5%+45.3%
3Y-44.3%-220.2%+175.9%
5Y-26.9%-342.4%+315.5%
10Y-147.0%-462.5%+315.5%
4.3.2.2. Operating Ratio

Measures how efficient Moderna Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 11.65 means that the operating costs are €11.65 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Moderna Inc:

  • The MRQ is 11.654. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.933. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ11.654TTM5.933+5.721
TTM5.933YOY5.590+0.344
TTM5.9335Y2.977+2.956
5Y2.97710Y4.131-1.153
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.6542.097+9.557
TTM5.9332.684+3.249
YOY5.5903.076+2.514
3Y4.2113.524+0.687
5Y2.9774.724-1.747
10Y4.1316.445-2.314
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Moderna Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Moderna Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 4.22Β means the company has €4.22 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Moderna Inc:

  • The MRQ is 4.218. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.092. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.218TTM4.092+0.126
TTM4.092YOY3.329+0.764
TTM4.0925Y3.432+0.660
5Y3.43210Y4.053-0.621
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2183.638+0.580
TTM4.0923.846+0.246
YOY3.3294.140-0.811
3Y3.3314.688-1.357
5Y3.4325.722-2.290
10Y4.0536.144-2.091
4.4.3.2. Quick Ratio

Measures if Moderna Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Moderna Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 2.76Β means the company can pay off €2.76 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Moderna Inc:

  • The MRQ is 2.762. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.733. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.762TTM2.733+0.029
TTM2.733YOY2.052+0.681
TTM2.7335Y1.855+0.878
5Y1.85510Y2.420-0.565
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7622.826-0.064
TTM2.7333.116-0.383
YOY2.0523.786-1.734
3Y2.0994.311-2.212
5Y1.8555.702-3.847
10Y2.4206.335-3.915
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Moderna Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Moderna IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Moderna Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.21Β means that Moderna Inc assets areΒ financed with 20.8% credit (debt) and the remaining percentage (100% - 20.8%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Moderna Inc:

  • The MRQ is 0.208. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.234. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.208TTM0.234-0.026
TTM0.234YOY0.254-0.020
TTM0.2345Y0.343-0.110
5Y0.34310Y0.328+0.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2080.327-0.119
TTM0.2340.349-0.115
YOY0.2540.332-0.078
3Y0.2540.340-0.086
5Y0.3430.346-0.003
10Y0.3280.378-0.050
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Moderna Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Moderna Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 26.2% means that company has €0.26 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Moderna Inc:

  • The MRQ is 0.262. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.306. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.262TTM0.306-0.044
TTM0.306YOY0.343-0.037
TTM0.3065Y0.650-0.344
5Y0.65010Y0.604+0.046
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2620.383-0.121
TTM0.3060.438-0.132
YOY0.3430.414-0.071
3Y0.3440.450-0.106
5Y0.6500.457+0.193
10Y0.6040.512+0.092
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Moderna Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Moderna Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -3.08 means the investor is paying €-3.08Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Moderna Inc:

  • The EOD is -3.365. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.084. Based on the earnings, the company is expensive. -2
  • The TTM is 125.609. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.365MRQ-3.084-0.281
MRQ-3.084TTM125.609-128.693
TTM125.609YOY6.203+119.406
TTM125.6095Y23.185+102.424
5Y23.18510Y17.835+5.350
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.365-2.399-0.966
MRQ-3.084-2.092-0.992
TTM125.609-2.625+128.234
YOY6.203-3.784+9.987
3Y45.774-3.762+49.536
5Y23.185-6.363+29.548
10Y17.835-7.055+24.890
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Moderna Inc:

  • The EOD is -2.807. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.573. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.215. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.807MRQ-2.573-0.234
MRQ-2.573TTM-0.215-2.358
TTM-0.215YOY-0.413+0.199
TTM-0.2155Y3.031-3.246
5Y3.03110Y1.457+1.574
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.807-3.299+0.492
MRQ-2.573-2.742+0.169
TTM-0.215-3.801+3.586
YOY-0.413-4.402+3.989
3Y13.100-5.140+18.240
5Y3.031-8.483+11.514
10Y1.457-9.296+10.753
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Moderna Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 1.19 means the investor is paying €1.19Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Moderna Inc:

  • The EOD is 1.298. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.190. Based on the equity, the company is underpriced. +1
  • The TTM is 2.333. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.298MRQ1.190+0.108
MRQ1.190TTM2.333-1.143
TTM2.333YOY3.166-0.832
TTM2.3335Y6.353-4.020
5Y6.35310Y6.361-0.008
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.2982.113-0.815
MRQ1.1901.856-0.666
TTM2.3332.125+0.208
YOY3.1662.454+0.712
3Y2.9952.492+0.503
5Y6.3533.668+2.685
10Y6.3614.364+1.997
4.6.2. Total Gains per Share

2.4. Latest News of Moderna Inc

Does Moderna Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Moderna Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-07-12
19:24
Moderna (NasdaqGS:MRNA) Added to Russell Midcap IndexesRead
2025-07-11
23:50
Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key InsightsRead
2025-07-11
21:30
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To KnowRead
2025-07-03
19:28
Moderna (NasdaqGS:MRNA) Joins Russell Midcap Indices In Late June 2025Read
2025-07-02
19:18
Robert F. Kennedy Jr. Just Did The Unexpected. He Helped Moderna.Read
2025-07-01
19:02
Improved Pharma initiates research and development programRead
2025-06-30
21:56
Sector Update: Health Care Stocks Higher Late AfternoonRead
2025-06-30
19:49
Sector Update: Health Care Stocks Advance Monday AfternoonRead
2025-06-20
23:50
Moderna (MRNA) Advances While Market Declines: Some Information for InvestorsRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets12,704,000
Total Liabilities2,638,000
Total Stockholder Equity10,066,000
 As reported
Total Liabilities 2,638,000
Total Stockholder Equity+ 10,066,000
Total Assets = 12,704,000

Assets

Total Assets12,704,000
Total Current Assets6,766,000
Long-term Assets5,938,000
Total Current Assets
Cash And Cash Equivalents 1,623,000
Short-term Investments 4,352,000
Net Receivables 78,000
Inventory 128,000
Other Current Assets 69,000
Total Current Assets  (as reported)6,766,000
Total Current Assets  (calculated)6,250,000
+/- 516,000
Long-term Assets
Property Plant Equipment 2,964,000
Goodwill 52,000
Long Term Investments 2,424,000
Intangible Assets 49,000
Long-term Assets Other 150,000
Long-term Assets  (as reported)5,938,000
Long-term Assets  (calculated)5,639,000
+/- 299,000

Liabilities & Shareholders' Equity

Total Current Liabilities1,604,000
Long-term Liabilities1,034,000
Total Stockholder Equity10,066,000
Total Current Liabilities
Accounts payable 226,000
Other Current Liabilities 209,000
Total Current Liabilities  (as reported)1,604,000
Total Current Liabilities  (calculated)435,000
+/- 1,169,000
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt745,000
Long-term Liabilities Other 40,000
Long-term Liabilities  (as reported)1,034,000
Long-term Liabilities  (calculated)785,000
+/- 249,000
Total Stockholder Equity
Retained Earnings 9,074,000
Total Stockholder Equity (as reported)10,066,000
Total Stockholder Equity (calculated)9,074,000
+/- 992,000
Other
Common Stock Shares Outstanding 386,623
Net Invested Capital 10,066,000
Net Working Capital 5,162,000
Property Plant and Equipment Gross 3,530,000



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
1,590,899
1,589,422
2,067,541
3,486,006
4,650,873
7,336,750
12,694,000
16,153,000
20,923,000
24,669,000
27,609,000
26,043,000
26,056,000
25,858,000
24,125,000
21,884,000
19,450,000
18,426,000
16,729,000
15,680,000
15,803,000
14,142,000
12,704,000
12,704,00014,142,00015,803,00015,680,00016,729,00018,426,00019,450,00021,884,00024,125,00025,858,00026,056,00026,043,00027,609,00024,669,00020,923,00016,153,00012,694,0007,336,7504,650,8733,486,0062,067,5411,589,4221,590,899
   > Total Current Assets 
1,094,466
1,128,804
1,249,936
2,796,744
3,577,211
6,297,879
11,703,000
10,969,000
13,425,000
16,071,000
16,350,000
13,563,000
14,297,000
13,431,000
12,122,000
10,599,000
10,799,000
10,325,000
9,600,000
9,661,000
9,666,000
8,099,000
6,766,000
6,766,0008,099,0009,666,0009,661,0009,600,00010,325,00010,799,00010,599,00012,122,00013,431,00014,297,00013,563,00016,350,00016,071,00013,425,00010,969,00011,703,0006,297,8793,577,2112,796,7441,249,9361,128,8041,094,466
       Cash And Cash Equivalents 
173,711
235,876
391,720
1,761,629
1,505,581
2,623,850
5,442,000
5,603,000
5,550,000
6,848,000
5,048,000
2,873,000
3,027,000
3,205,000
3,441,000
3,801,000
2,932,000
2,907,000
2,051,000
2,478,000
1,644,000
1,927,000
1,623,000
1,623,0001,927,0001,644,0002,478,0002,051,0002,907,0002,932,0003,801,0003,441,0003,205,0003,027,0002,873,0005,048,0006,848,0005,550,0005,603,0005,442,0002,623,8501,505,5811,761,629391,720235,876173,711
       Short-term Investments 
884,829
867,124
825,981
955,384
1,770,721
1,983,758
2,293,000
2,387,000
3,356,000
3,879,000
5,067,000
5,024,000
5,321,000
6,697,000
5,482,000
4,658,000
4,641,000
5,697,000
6,472,000
6,010,000
5,223,000
5,098,000
4,352,000
4,352,0005,098,0005,223,0006,010,0006,472,0005,697,0004,641,0004,658,0005,482,0006,697,0005,321,0005,024,0005,067,0003,879,0003,356,0002,387,0002,293,0001,983,7581,770,721955,384825,981867,124884,829
       Net Receivables 
18,120
16,297
18,793
57,850
213,453
1,410,527
3,228,000
2,071,000
3,199,000
3,296,000
3,364,000
2,844,000
2,821,000
1,664,000
1,521,000
647,000
2,146,000
892,000
137,000
163,000
1,564,000
358,000
78,000
78,000358,0001,564,000163,000137,000892,0002,146,000647,0001,521,0001,664,0002,821,0002,844,0003,364,0003,296,0003,199,0002,071,0003,228,0001,410,527213,45357,85018,79316,29718,120
       Other Current Assets 
0
1,032
1,032
1,032
25,022
217,570
224,000
206,000
250,000
481,000
724,000
791,000
774,000
481,000
435,000
385,000
345,000
88,000
68,000
31,000
46,000
58,000
69,000
69,00058,00046,00031,00068,00088,000345,000385,000435,000481,000774,000791,000724,000481,000250,000206,000224,000217,57025,0221,0321,0321,0320
   > Long-term Assets 
496,433
460,618
817,605
689,262
1,073,662
1,038,871
991,000
5,184,000
7,498,000
8,598,000
11,259,000
12,480,000
11,759,000
12,427,000
12,003,000
11,285,000
8,651,000
8,101,000
7,129,000
6,019,000
6,137,000
6,043,000
5,938,000
5,938,0006,043,0006,137,0006,019,0007,129,0008,101,0008,651,00011,285,00012,003,00012,427,00011,759,00012,480,00011,259,0008,598,0007,498,0005,184,000991,0001,038,8711,073,662689,262817,605460,618496,433
       Property Plant Equipment 
0
287,909
302,599
321,985
368,593
387,090
461,000
898,000
960,000
1,383,000
1,473,000
1,446,000
2,132,000
2,139,000
2,135,000
2,410,000
2,717,000
2,658,000
2,760,000
2,971,000
3,165,000
2,955,000
2,964,000
2,964,0002,955,0003,165,0002,971,0002,760,0002,658,0002,717,0002,410,0002,135,0002,139,0002,132,0001,446,0001,473,0001,383,000960,000898,000461,000387,090368,593321,985302,599287,9090
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
52,000
52,000
52,000
52,000
52,000
52,000
52,000
52,000
52,000
52,00052,00052,00052,00052,00052,00052,00052,00052,00000000000000000
       Long Term Investments 
279,860
159,987
502,479
354,916
691,969
638,848
468,000
4,207,000
6,442,000
6,843,000
9,171,000
10,162,000
8,655,000
8,318,000
7,442,000
6,105,000
5,273,000
4,743,000
3,691,000
2,357,000
2,358,000
2,508,000
2,424,000
2,424,0002,508,0002,358,0002,357,0003,691,0004,743,0005,273,0006,105,0007,442,0008,318,0008,655,00010,162,0009,171,0006,843,0006,442,0004,207,000468,000638,848691,969354,916502,479159,987279,860
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,000
46,000
45,000
44,000
43,000
42,000
41,000
40,000
49,000
49,00040,00041,00042,00043,00044,00045,00046,00048,00000000000000000
       Long-term Assets Other 
12,885
12,722
12,527
12,361
13,100
12,933
12,000
13,000
15,000
46,000
94,000
87,000
52,000
988,000
1,164,000
1,290,000
661,000
181,000
180,000
195,000
85,000
171,000
150,000
150,000171,00085,000195,000180,000181,000661,0001,290,0001,164,000988,00052,00087,00094,00046,00015,00013,00012,00012,93313,10012,36112,52712,72212,885
> Total Liabilities 
339,092
414,612
426,667
539,121
1,891,075
4,775,375
8,856,000
9,449,000
10,799,000
10,524,000
10,534,000
8,058,000
8,064,000
6,735,000
5,262,000
4,935,000
5,995,000
4,572,000
3,912,000
3,968,000
3,876,000
3,241,000
2,638,000
2,638,0003,241,0003,876,0003,968,0003,912,0004,572,0005,995,0004,935,0005,262,0006,735,0008,064,0008,058,00010,534,00010,524,00010,799,0009,449,0008,856,0004,775,3751,891,075539,121426,667414,612339,092
   > Total Current Liabilities 
147,842
143,115
134,582
161,647
1,473,561
4,388,808
8,441,000
8,840,000
9,957,000
9,128,000
9,238,000
6,812,000
6,807,000
4,923,000
3,499,000
3,123,000
4,385,000
3,015,000
2,380,000
2,363,000
2,201,000
2,206,000
1,604,000
1,604,0002,206,0002,201,0002,363,0002,380,0003,015,0004,385,0003,123,0003,499,0004,923,0006,807,0006,812,0009,238,0009,128,0009,957,0008,840,0008,441,0004,388,8081,473,561161,647134,582143,115147,842
       Accounts payable 
11,737
7,090
11,034
18,817
20,521
18,359
8,000
77,000
87,000
302,000
199,000
181,000
330,000
487,000
389,000
310,000
494,000
520,000
183,000
279,000
373,000
405,000
226,000
226,000405,000373,000279,000183,000520,000494,000310,000389,000487,000330,000181,000199,000302,00087,00077,0008,00018,35920,52118,81711,0347,09011,737
       Other Current Liabilities 
5,835
68,818
68,891
57,742
1,252,312
3,888,134
7,652,000
7,745,000
8,554,000
7,143,000
7,384,000
5,034,000
4,710,000
2,407,000
1,594,000
1,392,000
1,690,000
41,000
165,000
17,000
18,000
181,000
209,000
209,000181,00018,00017,000165,00041,0001,690,0001,392,0001,594,0002,407,0004,710,0005,034,0007,384,0007,143,0008,554,0007,745,0007,652,0003,888,1341,252,31257,74268,89168,8185,835
   > Long-term Liabilities 
191,250
271,497
292,085
377,474
417,514
386,567
415,000
609,000
842,000
1,396,000
1,296,000
1,246,000
1,257,000
1,812,000
1,763,000
1,812,000
1,610,000
1,557,000
1,532,000
1,605,000
1,675,000
1,035,000
1,034,000
1,034,0001,035,0001,675,0001,605,0001,532,0001,557,0001,610,0001,812,0001,763,0001,812,0001,257,0001,246,0001,296,0001,396,000842,000609,000415,000386,567417,514377,474292,085271,497191,250
       Capital Lease Obligations Min Short Term Debt
33,801
132,364
147,849
167,772
212,294
207,295
234,000
603,000
583,000
916,000
947,000
728,000
1,261,000
1,004,000
927,000
947,000
1,272,000
1,243,000
1,237,000
1,269,000
1,355,000
747,000
745,000
745,000747,0001,355,0001,269,0001,237,0001,243,0001,272,000947,000927,0001,004,0001,261,000728,000947,000916,000583,000603,000234,000207,295212,294167,772147,849132,36433,801
       Long-term Liabilities Other 
161
138
1,247
1,224
2,183
1,853
2,000
1,000
1,000
76,000
91,000
113,000
81,000
135,000
163,000
173,000
172,000
21,000
262,000
266,000
35,000
36,000
40,000
40,00036,00035,000266,000262,00021,000172,000173,000163,000135,00081,000113,00091,00076,0001,0001,0002,0001,8532,1831,2241,247138161
> Total Stockholder Equity
1,251,807
1,174,810
1,640,874
2,946,885
2,759,798
2,561,375
3,838,000
6,704,000
10,124,000
14,145,000
17,075,000
17,985,000
17,992,000
19,123,000
18,863,000
16,949,000
13,455,000
13,854,000
12,817,000
11,712,000
11,927,000
10,901,000
10,066,000
10,066,00010,901,00011,927,00011,712,00012,817,00013,854,00013,455,00016,949,00018,863,00019,123,00017,992,00017,985,00017,075,00014,145,00010,124,0006,704,0003,838,0002,561,3752,759,7982,946,8851,640,8741,174,8101,251,807
   Common Stock
0
34
37
39
40
40
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000040403937340
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
1,804
-6,127
8,256
4,784
3,004
1,000
16,000
31,000
-24,000
-184,000
-240,000
-351,000
-370,000
0
-263,000
-211,000
0
0
0
0
0
0
000000-211,000-263,0000-370,000-351,000-240,000-184,000-24,00031,00016,0001,0003,0044,7848,256-6,1271,8040



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,199,000
Cost of Revenue-1,464,000
Gross Profit1,735,0001,735,000
 
Operating Income (+$)
Gross Profit1,735,000
Operating Expense-7,144,000
Operating Income-3,945,000-5,409,000
 
Operating Expense (+$)
Research Development4,543,000
Selling General Administrative1,174,000
Selling And Marketing Expenses-
Operating Expense7,144,0005,717,000
 
Net Interest Income (+$)
Interest Income425,000
Interest Expense-24,000
Other Finance Cost-0
Net Interest Income401,000
 
Pretax Income (+$)
Operating Income-3,945,000
Net Interest Income401,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-3,607,000-3,882,000
EBIT - interestExpense = -24,000
-3,561,000
-3,537,000
Interest Expense24,000
Earnings Before Interest and Taxes (EBIT)--3,583,000
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-3,607,000
Tax Provision--46,000
Net Income From Continuing Ops-3,561,000-3,561,000
Net Income-3,561,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-63,000-401,000
 

Technical Analysis of Moderna Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Moderna Inc. The general trend of Moderna Inc is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Moderna Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Moderna Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Moderna Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 31.50 < 34.57 < 34.90.

The bearish price targets are: 25.90 > 25.18 > 24.91.

Know someone who trades $0QF? Share this with them.πŸ‘‡

Moderna Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Moderna Inc. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Moderna Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Moderna Inc. The current macd is 1.3621417.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Moderna Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Moderna Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Moderna Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Moderna Inc Daily Moving Average Convergence/Divergence (MACD) ChartModerna Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Moderna Inc. The current adx is 30.30.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Moderna Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Moderna Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Moderna Inc. The current sar is 24.19.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Moderna Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Moderna Inc. The current rsi is 70.33. The current phase is Overbought in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Overbought in bear market: Short-term excessive buying, potential for relief decline. Consider shorting, be cautious of potential pullback. -1
  • Trending down: The RSI is trending down. -1
Moderna Inc Daily Relative Strength Index (RSI) ChartModerna Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Moderna Inc. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Moderna Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Moderna Inc Daily Stochastic Oscillator ChartModerna Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Moderna Inc. The current cci is 154.20.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Moderna Inc Daily Commodity Channel Index (CCI) ChartModerna Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Moderna Inc. The current cmo is 53.59.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Moderna Inc Daily Chande Momentum Oscillator (CMO) ChartModerna Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Moderna Inc. The current willr is -11.3442623.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Moderna Inc Daily Williams %R ChartModerna Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Moderna Inc.

Moderna Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Moderna Inc. The current atr is 1.07172522.

Moderna Inc Daily Average True Range (ATR) ChartModerna Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Moderna Inc. The current obv is -173,564.

Moderna Inc Daily On-Balance Volume (OBV) ChartModerna Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Moderna Inc. The current mfi is 93.83.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Moderna Inc Daily Money Flow Index (MFI) ChartModerna Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Moderna Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-20 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-24 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-04 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-07 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-11 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-13 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-17 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-18 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-19 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-21 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-24 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-25 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-28 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-31 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-01 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-23 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-25 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-28 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-05 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-06 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-08 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-15 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-16 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-20 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-22 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-23 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-03 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-04 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-06 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-09 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-12 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-13 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-16 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-24 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-25 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-30 00:00:00MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-01 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-02 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-10 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Moderna Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Moderna Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.326
Ma 20Greater thanMa 5024.516
Ma 50Greater thanMa 10023.753
Ma 100Greater thanMa 20025.806
OpenGreater thanClose29.320
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Moderna Inc with someone you think should read this too:
  • Are you bullish or bearish on Moderna Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Moderna Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Moderna Inc

I send you an email if I find something interesting about Moderna Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Moderna Inc.

Receive notifications about Moderna Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.